0001387131-22-006923.txt : 20220610
0001387131-22-006923.hdr.sgml : 20220610
20220610185954
ACCESSION NUMBER: 0001387131-22-006923
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220609
FILED AS OF DATE: 20220610
DATE AS OF CHANGE: 20220610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zanganeh Maky
CENTRAL INDEX KEY: 0001507650
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37744
FILM NUMBER: 221010317
MAIL ADDRESS:
STREET 1: MAKY ZANGANEH & ASSOCIATES
STREET 2: 51 ADAM WAY
CITY: ATHERTON
STATE: CA
ZIP: 94027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pulse Biosciences, Inc.
CENTRAL INDEX KEY: 0001625101
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 465696597
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3957 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: 510-906-4600
MAIL ADDRESS:
STREET 1: 3957 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
FORMER COMPANY:
FORMER CONFORMED NAME: Electroblate, Inc.
DATE OF NAME CHANGE: 20141113
4
1
zangeneh-form4_060922.xml
X0306
4
2022-06-09
0
0001625101
Pulse Biosciences, Inc.
PLSE
0001507650
Zanganeh Maky
C/O PULSE BIOSCIENCES, INC.
3957 POINT EDEN WAY
HAYWARD
CA
94545
1
0
0
0
Common Stock
2022-06-09
4
X
0
86668
A
442168
D
Common Stock
27000
I
Immediate family member 1
Common Stock
14000
I
Immediate family member 2
Common Stock
107074
I
Immediate family member 3
Warrant (right to buy)
2.05
2022-06-09
4
P
0
86668
A
2022-06-09
2027-06-09
Common Stock
86668
86668
D
The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC.
Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05.
/s/ Kenneth B. Stratton, as Attorney-in-Fact
2022-06-10